Fluanisone 500 mg | 99.85%
TargetMol
Fluanisone is a butyrophenone derivative with sedative properties. It is a typical antipsychotic and is used in the treatment of schizophrenia.
More Information Supplier PageFluanisone
Search Results
Fluanisone 200 mg | 99.85%
TargetMol
Fluanisone is a butyrophenone derivative with sedative properties. It is a typical antipsychotic and is used in the treatment of schizophrenia.
More Information Supplier PageFluanisone
Fluanisone 100 mg | 99.85%
TargetMol
Fluanisone is a butyrophenone derivative with sedative properties. It is a typical antipsychotic and is used in the treatment of schizophrenia.
More Information Supplier PageFluanisone
Fluanisone 50 mg | 99.85%
TargetMol
Fluanisone is a butyrophenone derivative with sedative properties. It is a typical antipsychotic and is used in the treatment of schizophrenia.
More Information Supplier PageFluanisone
Fluanisone 25 mg | 99.85%
TargetMol
Fluanisone is a butyrophenone derivative with sedative properties. It is a typical antipsychotic and is used in the treatment of schizophrenia.
More Information Supplier PageFluanisone
Diroximel fumarate 5 mg | Purity Not Available
TargetMol
Diroximel fumarate, a prodrug of monomethyl fumarate in a controlled-release formulation, rapidly and potently converts to MMF in the body.
More Information Supplier PageDiroximel fumarate
Crisaborole 100 mg | Purity Not Available
TargetMol
Crisaborole
Crisaborole 200 mg | Purity Not Available
TargetMol
Crisaborole
THZ531 1 mg | Purity Not Available
TargetMol
THZ531 is a covalent inhibitor of both CDK12(IC50=158 nM) and CDK13(IC50=69 nM).
More Information Supplier PageTHZ531
AZD2098 10 mg | 99.80%
TargetMol
AZD2098 is a potent CC-chemokine receptor 4 (CCR4) inhibitor used for asthma research.
More Information Supplier PageAZD2098
